Cytokeratin 7 抗体 (AA 251-350) (PE)
Quick Overview for Cytokeratin 7 抗体 (AA 251-350) (PE) (ABIN6988414)
抗原
See all Cytokeratin 7 (KRT7) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 251-350
-
交叉反应
- 人, 小鼠
-
预测反应
- Rat
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human of human CK7
-
亚型
- IgG
-
-
-
-
应用备注
- FCM 1:20-100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
-
别名
- CK7
-
背景
-
Synonyms: K7, CK7, SCL, K2C7, Keratin, type II cytoskeletal 7, Cytokeratin-7, CK-7, Keratin-7, Sarcolectin, Type-II keratin Kb7, KRT7
Background: Blocks interferon-dependent interphase and stimulates DNA synthesis in cells. Involved in the translational regulation of the human papillomavirus type 16 E7 mRNA (HPV16 E7).
-
基因ID
- 3855
-
UniProt
- P08729
抗原
-